Literature DB >> 28751367

Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model.

Karin J C Sanders1, Samuel Y Ash2, George R Washko2, Felix M Mottaghy3,4, Annemie M W J Schols1.   

Abstract

The clinical manifestations of chronic obstructive pulmonary disease (COPD) reflect an aggregate of multiple pulmonary and extrapulmonary processes. It is increasingly clear that full assessment of these processes is essential to characterize disease burden and to tailor therapy. Medical imaging has advanced such that it is now possible to obtain in vivo insight in the presence and severity of lung disease-associated features. In this review, we have assembled data from multiple disciplines of medical imaging research to review the role of imaging in characterization of COPD. Topics include imaging of the lungs, body composition, and extrapulmonary tissue metabolism. The primary focus is on imaging modalities that are widely available in clinical care settings and that potentially contribute to describing COPD heterogeneity and enhance our insight in underlying pathophysiological processes and their structural and functional effects.

Entities:  

Keywords:  body composition; chronic obstructive pulmonary disease; imaging; lung

Mesh:

Year:  2017        PMID: 28751367      PMCID: PMC6050198          DOI: 10.1152/japplphysiol.00143.2017

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  90 in total

1.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.

Authors:  J H Austin; N L Müller; P J Friedman; D M Hansell; D P Naidich; M Remy-Jardin; W R Webb; E A Zerhouni
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

2.  Dual-energy X-ray absorptiometry: fat estimation errors due to variation in soft tissue hydration.

Authors:  A Pietrobelli; Z Wang; C Formica; S B Heymsfield
Journal:  Am J Physiol       Date:  1998-05

3.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

4.  Blue bloater: pink puffer.

Authors: 
Journal:  Br Med J       Date:  1968-06-15

5.  The pulmonary angiogram in chronic bronchitis and emphysema.

Authors:  G D Scarrow
Journal:  Proc R Soc Med       Date:  1965-09

6.  Nutritional assessment and therapy in COPD: a European Respiratory Society statement.

Authors:  Annemie M Schols; Ivone M Ferreira; Frits M Franssen; Harry R Gosker; Wim Janssens; Maurizio Muscaritoli; Christophe Pison; Maureen Rutten-van Mölken; Frode Slinde; Michael C Steiner; Ruzena Tkacova; Sally J Singh
Journal:  Eur Respir J       Date:  2014-09-18       Impact factor: 16.671

7.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

8.  Cold-activated brown adipose tissue in healthy men.

Authors:  Wouter D van Marken Lichtenbelt; Joost W Vanhommerig; Nanda M Smulders; Jamie M A F L Drossaerts; Gerrit J Kemerink; Nicole D Bouvy; Patrick Schrauwen; G J Jaap Teule
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

9.  Obesity is a risk factor for dyspnea but not for airflow obstruction.

Authors:  Don D Sin; Richard L Jones; S F Paul Man
Journal:  Arch Intern Med       Date:  2002-07-08

10.  Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers.

Authors:  Peter J Castaldi; Raúl San José Estépar; Carlos S Mendoza; Craig P Hersh; Nan Laird; James D Crapo; David A Lynch; Edwin K Silverman; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

View more
  2 in total

1.  Identification of Chronic Obstructive Pulmonary Disease Axes That Predict All-Cause Mortality: The COPDGene Study.

Authors:  Gregory L Kinney; Stephanie A Santorico; Kendra A Young; Michael H Cho; Peter J Castaldi; Raul San José Estépar; James C Ross; Jennifer G Dy; Barry J Make; Elizabeth A Regan; David A Lynch; Douglas C Everett; Sharon M Lutz; Edwin K Silverman; George R Washko; James D Crapo; John E Hokanson
Journal:  Am J Epidemiol       Date:  2018-10-01       Impact factor: 4.897

2.  Distinguishing Smoking-Related Lung Disease Phenotypes Via Imaging and Molecular Features.

Authors:  Ehab Billatos; Samuel Y Ash; Fenghai Duan; Ke Xu; Justin Romanoff; Helga Marques; Elizabeth Moses; MeiLan K Han; Elizabeth A Regan; Russell P Bowler; Stefanie E Mason; Tracy J Doyle; Rubén San José Estépar; Ivan O Rosas; James C Ross; Xiaohui Xiao; Hanqiao Liu; Gang Liu; Gauthaman Sukumar; Matthew Wilkerson; Clifton Dalgard; Christopher Stevenson; Duncan Whitney; Denise Aberle; Avrum Spira; Raúl San José Estépar; Marc E Lenburg; George R Washko
Journal:  Chest       Date:  2020-09-16       Impact factor: 10.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.